Angiotensin Ii

Records for this ingredient, by country (identity only).

ATC C01CX09 · 3 markets · 5 records

Angiotensin Ii 3 markets · 5 records Forms
Filters
MarketUS 3GB 1EU 1

US 3 records · 2 shown of 2 Source openFDA NDC Directory · Data as of 2026-10-23

  • 2.5 mg per mL / per unit basis not statedinjectionGiaprezaManufacturer: Gland Pharma Limited
  • 0.5 mg per mL / per unit basis not statedinjectionGiapreza

GB 1 records · 1 shown of 1 Source NHSBSA dm+d · Data as of 2026-10-19

  • 2.5 mg/1 mLinjectionGiapreza 2.5mg/1ml concentrate for solution for infusion vials

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.